The Global Gastroesophageal Reflux Disease Device Market is expected to grow at a CAGR of around 2.97% during the forecast period, i.e., 2021-26, says MarkNtel Advisors in their research report. Gastroesophageal reflux disease (GERD) is a condition that occurs when there is a reverse flow of stomach contents back into the esophagus. Frequent changes in consumption of fast food, alcohol, or aerated drinks and mounting stress levels among people are the prime causes of Gastroesophageal Reflux Disease (GERD). Hence, numerous environmental factors and the rapid lifestyle evolution like adopting sedentary habits shall drive the demand for Gastroesophageal Reflux Disease Devices in the coming years.
Moreover, there has been a significant surge in younger patients suffering from GERD over the last decade, especially those aged between 30–39 years. This increasing number of GERD patients aids the demand for Gastroesophageal Reflux Disease Devices, which, in turn, fuels the overall market growth, further states the research report, “Global Gastroesophageal Reflux Disease Device Market Analysis, 2021.”
Demand for MUSE- Medigus Ultrasonic Surgical Endostapler to Witness Sturdy Growth During 2021-26
MUSE (Medigus Ultrasonic Surgical Endostapler) is an endoscopic device that uses the latest technological advancements to deliver patient-friendly treatment procedures, such as Transoral Fundoplication for GERD treatment. The mounting demand for MUSE is because it is considered a safe & minimally invasive alternative for long-term treatment of GERD. Moreover, it helps reducing hospital stays & post-procedure recovery times as compared to laparoscopic procedures, which are more invasive.
“Global Gastroesophageal Reflux Disease Device Market Analysis, 2021” highlights insights on the market potential & opportunities, along with business strategies to enhance the overall market growth. The report offers an overview of leading market players and their recent developments. Moreover, the report provides incredible market opportunities & emerging trends to help stakeholders make appropriate decisions before investing.
North America Acquired the Largest Share of the Global Gastroesophageal Reflux Disease Device Market
GERD is the most common disease diagnosed in the US due to the mounting obesity rate & rapidly increasing geriatric population. Around 20% of the US population faces GERD symptoms once a week. Additionally, a rapid increase in lifestyle-related issues like frequent smoking and alcohol consumption is another crucial aspect leading to GERD, which, in turn, increases the demand for GERD devices across North America and boosts the regional market.
According to MarkNtel Advisors, the leading industry players in the Global Gastroesophageal Reflux Disease Device Market are Torax Medical, Inc., Pentax Medical, Medtronics Plc, MediGus Limited, Essai Co, Ltd., Medari Theraputics Inc., Takeda Pharmaceuticals Co. Ltd., Johnson & Johnson Services Inc., Olympus Corporation, and Diversatek, Inc.
Key Questions Answered in the Study